Immune Thrombocytopenia Sleep Mattress Canada: ITP Guide

8 min read

Table of Contents

• Understanding Immune Thrombocytopenia (ITP)
• How ITP Disrupts Sleep: Multiple Pathways
• Bruising, Petechiae, and Mattress Pressure
• ITP Fatigue: The Exhaustion That Does Not Let You Rest
• Corticosteroid-Induced Insomnia and Sleep Strategies
• Other ITP Medications and Sleep Effects
• Bleeding Anxiety and Nighttime Worry
• The Science of Gentle Pressure for Low Platelet Counts
• Essential Mattress Features for ITP Patients
• Sleep Positions for ITP Comfort and Safety
• Bedroom Setup for ITP Safety
• Canadian ITP Resources and Support
• The Restonic ComfortCare for ITP Patients
• Frequently Asked Questions
• Sources

Understanding Immune Thrombocytopenia (ITP)

Immune thrombocytopenia, formerly known as idiopathic thrombocytopenic purpura, is an autoimmune condition in which the body's immune system mistakenly attacks and destroys its own platelets. Platelets are the small blood cells responsible for forming clots to stop bleeding. When platelet counts drop below normal levels (typically below 100 x 10^9 per litre, with normal being 150 to 400 x 10^9 per litre), the risk of bruising and bleeding increases significantly.

ITP can be acute (lasting less than 12 months, more common in children) or chronic (lasting 12 months or longer, more common in adults). In Canada, an estimated 3 to 4 per 100,000 adults develop ITP each year, making it one of the more common autoimmune blood disorders. The condition affects people of all ages but has a peak incidence in young women (20 to 40 years) and in older adults (over 60 years).

The symptoms of ITP vary widely depending on the platelet count. Patients with mildly reduced counts (50 to 100 x 10^9/L) may have few or no symptoms. Those with moderately low counts (20 to 50 x 10^9/L) may experience easy bruising, prolonged bleeding from cuts, and petechiae (tiny pinpoint red or purple spots on the skin caused by bleeding under the surface). Patients with severely low counts (below 20 x 10^9/L) are at risk for spontaneous bleeding, including nosebleeds, gum bleeding, heavy menstrual bleeding, and rarely, internal bleeding.

What often surprises both patients and healthcare providers is how profoundly ITP affects quality of life beyond the visible bleeding symptoms. Fatigue is reported by up to 70 to 80 percent of ITP patients and is considered one of the most burdensome symptoms of the disease. Sleep disruption is extremely common, caused by the direct physical effects of the disease, the side effects of treatment, and the psychological burden of living with an unpredictable autoimmune condition. These quality-of-life impacts are increasingly recognized as important treatment targets alongside platelet counts.

The unpredictable nature of ITP adds a unique dimension to the sleep challenge. Unlike conditions with stable, predictable symptoms, ITP can fluctuate dramatically. Platelet counts may drop suddenly due to immune flares, infections, or stress, creating periods of heightened bleeding risk that increase anxiety. Conversely, platelet counts may rise during remission periods, only to drop again unexpectedly. This unpredictability creates a chronic state of vigilance that interferes with the psychological relaxation needed for sleep.

How ITP Disrupts Sleep: Multiple Pathways

ITP affects sleep through an interconnected web of physical, pharmacological, and psychological factors. Understanding these pathways helps identify the most effective strategies for improvement.

Physical symptoms: The most direct sleep disruptors in ITP are the physical symptoms of low platelets. Bruising causes tenderness that makes certain sleeping positions uncomfortable. Petechiae, while usually painless, can cause itching or skin sensitivity. Nosebleeds that occur during sleep can cause choking or coughing that fragments sleep. Heavy menstrual bleeding (in women with ITP) creates the same practical nighttime management challenges experienced by women with VWD. Gum bleeding can cause an unpleasant taste in the mouth that interferes with sleep onset.

Treatment side effects: The medications used to treat ITP are among the most sleep-disruptive drugs in medicine. Corticosteroids (prednisone, dexamethasone), which are the first-line treatment for most ITP patients, are notorious for causing insomnia, agitation, and mood disturbance. Thrombopoietin receptor agonists (eltrombopag, romiplostim), used for chronic ITP, can cause headaches and fatigue. Rituximab and other immunosuppressants can cause fatigue and general malaise. Splenectomy, while not a medication, can affect immune function and general well-being in ways that influence sleep.

Psychological impact: The chronic uncertainty of ITP creates psychological distress that significantly affects sleep. Fear of a sudden drop in platelet count, worry about bleeding during sleep, frustration with fatigue that does not improve with rest, and the emotional toll of managing a chronic condition all contribute to anxiety and depression that are well-established barriers to healthy sleep. Studies have shown that up to 40 percent of ITP patients report significant anxiety or depressive symptoms.

Immune dysregulation: As an autoimmune condition, ITP involves fundamental alterations in immune function that may directly affect sleep biology. Pro-inflammatory cytokines, the signalling molecules that drive the immune attack on platelets, also influence sleep regulation. Elevated levels of certain cytokines (particularly interleukin-6 and tumour necrosis factor-alpha) have been associated with both ITP disease activity and sleep disturbance. This suggests a biological link between immune flares and sleep disruption that goes beyond the symptomatic effects of low platelets.

Bruising, Petechiae, and Mattress Pressure

Bruising and petechiae are the most visible manifestations of ITP and have a direct relationship with mattress pressure that makes mattress selection critically important for these patients.

ITP bruises differ from bruises in people with normal platelet counts in several important ways. They tend to be larger, appear with less mechanical provocation, take longer to resolve, and may be more tender. When platelet counts are very low (below 20 x 10^9/L), bruises can develop from pressure alone, without any impact or trauma. This means that the sustained pressure of lying on a mattress for hours can potentially cause new bruises to form, particularly at pressure points where body weight is most concentrated.

Petechiae are even more sensitive to pressure than bruises. These tiny (1 to 2 millimetre) spots result from the rupture of individual capillaries and can appear in areas of dependent pressure or friction. Some ITP patients notice petechiae developing on the side they sleep on, particularly on the skin of the shoulder, hip, or cheek that is pressed against the mattress or pillow. While petechiae are generally not dangerous, their appearance can be distressing and serves as a visible reminder of the bleeding risk.

The relationship between mattress pressure and platelet-related bleeding follows a dose-response pattern. At normal platelet counts (150 to 400 x 10^9/L), the pressures generated by any standard mattress are unlikely to cause bruising. As platelet counts drop below 50 x 10^9/L, the threshold for pressure-induced capillary damage decreases, and mattress pressure becomes a more relevant concern. Below 20 x 10^9/L, even moderate mattress pressures can contribute to bruising, making gentle pressure distribution essential.

The practical challenge for ITP patients is that platelet counts can fluctuate, sometimes dramatically, over the course of weeks or even days. A mattress that provides adequate pressure relief during periods of very low counts will also work well during periods of higher counts (a softer mattress does not become problematic when platelets improve). This means it is generally better to choose a mattress based on the lowest platelet counts you typically experience rather than your average or highest counts.

Surface friction is another pressure-related concern for ITP patients. When you move on a mattress surface, the friction between your skin and the sheet (and between the sheet and the mattress cover) creates shearing forces that can damage capillaries parallel to the skin surface. A smooth mattress cover and smooth, high-quality sheets reduce this shearing force. Satin or sateen weave sheets are particularly smooth and may be beneficial for ITP patients who are prone to friction-related petechiae.

ITP Fatigue: The Exhaustion That Does Not Let You Rest

Fatigue in ITP is increasingly recognized as one of the most significant quality-of-life issues for patients, often rated as more burdensome than the bleeding symptoms themselves. Understanding the nature of ITP fatigue is essential for developing effective sleep strategies.

ITP fatigue is distinct from normal tiredness in several important ways. It is disproportionate to activity level, meaning patients feel exhausted even after minimal physical or mental exertion. It is not fully relieved by rest or sleep, which is one of its most frustrating characteristics. It has both physical and cognitive components, with patients reporting not just bodily exhaustion but also difficulty concentrating, remembering, and making decisions (sometimes called "brain fog"). And it can fluctuate independently of platelet counts, persisting even when counts are in the normal range during treatment.

The causes of ITP fatigue are multifactorial and not fully understood. Contributing factors include chronic immune activation (the same inflammatory cytokines that destroy platelets also cause fatigue), anaemia from bleeding, medication side effects (corticosteroids can cause fatigue even as they also cause insomnia), reduced physical activity (both from fatigue itself and from fear of bleeding), and psychological distress (anxiety and depression both cause fatigue). Sleep disruption itself is both a cause and consequence of fatigue, creating a self-reinforcing cycle.

The fatigue-sleep paradox in ITP is particularly challenging. Patients are profoundly tired but cannot achieve the deep, restorative sleep that would provide genuine recovery. They may spend long hours in bed but sleep lightly, wake frequently, and rise feeling unrefreshed. This pattern of non-restorative sleep can lead to a phenomenon called sleep effort, where the anxiety about not sleeping well becomes itself a barrier to sleep. Patients lie in bed trying harder and harder to fall asleep, which activates the stress response and pushes sleep further away.

The impact of ITP fatigue on daily functioning should not be underestimated. Studies using validated fatigue assessment tools have shown that ITP patients report fatigue levels comparable to those seen in cancer patients undergoing treatment. Many patients report that fatigue affects their ability to work, maintain relationships, exercise, and perform daily tasks. Sleep improvement is one of the most direct ways to address this fatigue, and the sleep environment, starting with the mattress, is one of the most modifiable factors in the equation.

Corticosteroid-Induced Insomnia and Sleep Strategies

Corticosteroids (primarily prednisone and dexamethasone) are the most commonly prescribed first-line treatment for ITP and are among the most sleep-disruptive medications in clinical medicine. Understanding how these drugs affect sleep and developing targeted strategies to mitigate their effects is essential for ITP patients.

Corticosteroids affect sleep through multiple mechanisms. They suppress the body's natural cortisol rhythm, which normally peaks in the early morning and declines through the day to facilitate sleep onset in the evening. Exogenous corticosteroids flood the system with cortisol-like activity, eliminating the natural evening decline and creating a state of physiological arousal that opposes sleep. They also stimulate the sympathetic nervous system (the "fight or flight" system), increasing heart rate, alertness, and mental activity. Additionally, they can cause mood changes ranging from euphoria to irritability that make psychological relaxation difficult.

The sleep effects of corticosteroids are dose-dependent. Higher doses cause more severe insomnia. Most ITP treatment protocols begin with a relatively high dose (typically prednisone 1 mg/kg per day, often 40 to 80 mg daily) and taper over weeks to months. The insomnia is typically worst in the first one to two weeks of treatment when doses are highest and may improve significantly as the dose decreases.

Specific sleep effects of corticosteroids include delayed sleep onset (taking 30 to 90+ minutes to fall asleep), reduced total sleep time, frequent awakenings during the night, early morning awakening (waking at 3 or 4 AM and being unable to return to sleep), vivid or disturbing dreams, and a subjective feeling of being "wired but tired" where the mind races despite physical exhaustion.

Timing strategies: Taking the corticosteroid dose as early in the morning as possible (ideally before 8 AM) allows the drug's stimulatory effects to peak during the day rather than the evening. Single daily dosing is preferable to divided doses if medically appropriate. If a split dose is required, taking both portions before noon can help minimize evening stimulation. Discuss these timing options with your haematologist.

Sleep environment optimization: When corticosteroid-induced insomnia is at its worst, every other sleep-promoting factor becomes more important. The bedroom should be completely dark, cool (18 to 19 degrees Celsius), and quiet. The mattress should be as comfortable as possible to eliminate physical discomfort that compounds the medication-induced arousal. Even small improvements in physical comfort can meaningfully reduce the total sleep disruption when a powerful chemical stimulant is working against sleep.

Relaxation techniques: Progressive muscle relaxation, guided meditation, and deep breathing exercises can partially counteract the sympathetic nervous system activation caused by corticosteroids. These techniques work by activating the parasympathetic ("rest and digest") nervous system, promoting the physiological state that is conducive to sleep. Practising these techniques daily, not just at bedtime, can improve their effectiveness over time.

Light management: Bright light exposure in the morning (within the first hour of waking) helps reset the circadian rhythm that corticosteroids disrupt. In the evening, minimize exposure to bright light and blue-spectrum light from screens for at least one to two hours before bedtime. This light management helps compensate for the cortisol rhythm disruption caused by the medication.

Activity timing: Regular physical activity helps promote sleep, but for ITP patients on corticosteroids, the timing and type of activity matter. Moderate activity earlier in the day (morning or early afternoon) can help burn off the excess energy that corticosteroids create. Avoid vigorous activity within four hours of bedtime. Choose low-impact activities (walking, swimming, gentle yoga) that are safe with low platelet counts.

Other ITP Medications and Sleep Effects

Beyond corticosteroids, several other ITP treatments can affect sleep in various ways. Understanding these effects helps patients and healthcare providers make treatment decisions that balance platelet count management with quality of life.

Thrombopoietin receptor agonists (TPO-RAs): Eltrombopag (Revolade in Canada) and romiplostim (Nplate) stimulate platelet production and are commonly used for chronic ITP. Eltrombopag can cause headaches, particularly in the initial weeks of treatment, that may disrupt sleep. It also has dietary restrictions (must be taken on an empty stomach, not within two hours of dairy or calcium) that may complicate bedtime routines. Romiplostim, given by subcutaneous injection, generally has fewer direct sleep effects but can cause headaches, fatigue, and joint pain that indirectly affect sleep quality.

Rituximab: This monoclonal antibody targets B cells and is used for ITP that has not responded to other treatments. Rituximab can cause fatigue, flu-like symptoms, and general malaise that may last for days to weeks after infusion. During these periods, patients often experience disrupted sleep patterns, alternating between excessive sleepiness and poor-quality sleep. The fatigue from rituximab typically improves over time as the body adjusts.

Fostamatinib (Tavalisse): This spleen tyrosine kinase inhibitor is a newer option for chronic ITP. Common side effects include diarrhoea, hypertension, and nausea, all of which can affect sleep. Diarrhoea may cause nighttime awakening. Hypertension can contribute to headaches and restlessness. Nausea, particularly if doses are taken in the evening, can delay sleep onset.

Immunosuppressants: Medications like mycophenolate mofetil, azathioprine, and cyclosporine are sometimes used for refractory ITP. These drugs can cause gastrointestinal effects, fatigue, and mood changes that affect sleep. Cyclosporine, in particular, can cause insomnia and tremor that disrupt sleep quality.

The key takeaway for ITP patients is that nearly every treatment option has some potential to affect sleep. This makes non-pharmacological sleep optimization, including mattress selection, sleep hygiene, and environmental factors, even more important. When medication side effects are working against sleep, having the best possible physical sleep environment helps preserve whatever sleep quality is achievable.

Bleeding Anxiety and Nighttime Worry

The psychological dimension of ITP's impact on sleep deserves dedicated attention because it is often the most persistent and most difficult-to-address factor, even when platelet counts are well controlled.

Bleeding anxiety refers to the chronic worry about the possibility of a bleeding event. For ITP patients, this anxiety may be focused on specific feared events (a nosebleed during sleep, a sudden drop in platelet count, internal bleeding) or may manifest as a more generalized sense of vulnerability and hypervigilance. At bedtime, when the day's distractions fall away and the mind is left with its own thoughts, this anxiety often intensifies.

The unpredictable nature of ITP fuels bleeding anxiety. Unlike conditions with stable, predictable courses, ITP can flare without warning. A patient who has had stable platelet counts for months can experience a sudden drop that requires emergency treatment. This unpredictability means that patients can never fully let their guard down, and the hypervigilance this creates is the opposite of the relaxed mental state needed for sleep onset.

Specific nighttime fears that ITP patients commonly report include: waking to find blood on the pillow from a nosebleed, developing a large bruise or haematoma while sleeping, bleeding from an unknown source during the night, and the more serious (though rare) concern about intracranial bleeding. While the actual statistical risk of serious overnight bleeding is low for most ITP patients, the perceived risk can be high, and it is the perceived risk that drives anxiety and sleep disruption.

The concept of "safety behaviours" is relevant for ITP patients. Safety behaviours are actions taken to prevent or minimize feared outcomes that actually maintain anxiety by preventing the person from learning that the feared outcome is unlikely. Examples include checking for bruises every few hours through the night (which causes awakenings), sleeping in an uncomfortable position to protect against bruising (which causes pain-related awakenings), or avoiding sleep altogether when platelet counts are low (which worsens fatigue and impairs immune function). Recognizing and gradually reducing safety behaviours, ideally with professional support, can significantly improve sleep quality.

The Science of Gentle Pressure for Low Platelet Counts

The clinical rationale for gentle mattress pressure in ITP is based on the same principles discussed in the VWD article but with additional considerations specific to the platelet-related bleeding mechanism.

In normal haemostasis (blood clotting), platelets are the first responders to vascular damage. When a capillary is compressed or damaged by external pressure, platelets quickly aggregate at the site, forming a platelet plug that stops blood from leaking into surrounding tissue. This process happens thousands of times daily without our awareness, as minor capillary damage from normal physical forces is constantly repaired.

In ITP, the reduced platelet count means that this repair process is compromised. With fewer platelets available, the platelet plug that forms at a damage site may be inadequate, allowing more blood to escape before the vessel is sealed. The result is larger bruises from the same mechanical force, slower resolution of bruises, and the possibility of bruising from forces that would cause no visible effect in a person with normal platelet counts.

The concept of pressure-time integral is useful for understanding how mattress pressure affects ITP patients. The damage to capillaries depends not just on the peak pressure but on the combination of pressure magnitude and duration. A brief, high-pressure contact (like bumping your hip on a table) may cause a bruise because the peak force exceeds the capillary's tolerance. But a prolonged, moderate-pressure contact (like lying on a mattress for eight hours) can also cause damage because the sustained compression, even at lower pressures, exceeds the tissue's tolerance over time.

For ITP patients, minimizing both the peak pressure and the duration of pressure at any single point is important. Peak pressure is minimized by using a mattress with good contouring and pressure distribution. Duration at any single point is minimized by using a responsive mattress that facilitates easy position changes, encouraging natural nocturnal movement that redistributes pressure throughout the night.

The mattress surface area in contact with the body is a key determinant of pressure distribution. A mattress that conforms closely to the body's contours maximizes this contact area, spreading weight over the largest possible surface. The more contact area, the lower the pressure at each point. Individually wrapped coils excel at maximizing contact area because each coil adjusts independently to the body's shape, filling in the gaps and valleys that rigid surfaces would leave unsupported.

Essential Mattress Features for ITP Patients

Based on the specific challenges of ITP discussed above, here are the mattress features that matter most for patients with this condition.

Exceptional pressure distribution: This is the non-negotiable feature for ITP patients. The mattress must distribute body weight as evenly as possible across the entire contact surface. Individually wrapped coils with high coil counts provide the most precise pressure distribution among spring-based mattresses. A minimum of 800 coils in a Queen size is recommended, with higher counts (1,000 to 1,400+) providing progressively better contouring.

Responsive comfort layers: The comfort layers should cushion without trapping. ITP patients need a surface that conforms quickly to body contours when they settle into position and releases quickly when they move. High-resilience polyurethane foam and natural latex both offer this responsive behaviour. Memory foam can provide excellent static pressure relief but may resist movement, making position changes more effortful and potentially increasing shearing forces against the skin during movement.

Smooth, low-friction surface: The mattress cover should be smooth and tightly woven to minimize friction against sheets and skin. Raised quilting patterns, decorative stitching, or textured fabrics can create micro-pressure points that may cause petechiae in patients with very low platelet counts. A clean, flat surface profile is preferable.

Temperature neutrality: Temperature regulation is important for ITP patients for several reasons. Corticosteroids can cause sweating and flushing. Immune activation may cause low-grade temperature elevations. Temperature discomfort causes more frequent position changes, increasing the skin-friction events that can contribute to petechiae. A mattress with good airflow (open coil system) and breathable comfort materials helps maintain a stable, comfortable temperature.

Adequate firmness for support without excess pressure: Medium to medium-soft firmness (4 to 5 on a 10-point scale) is generally optimal for ITP patients. This range provides enough structural support to maintain spinal alignment while keeping peak pressures at the lowest practical levels. Patients who sleep primarily on their backs may tolerate a slightly firmer surface (5 to 6), while dedicated side sleepers should lean toward the softer end (4 to 5).

Strong edge support: Dizziness and lightheadedness can occur in ITP patients due to anaemia from bleeding or medication side effects. Reinforced mattress edges provide a stable platform for sitting on the edge of the bed during the transition from lying to standing, reducing fall risk during moments of dizziness.

Sleep Positions for ITP Comfort and Safety

Sleep positioning for ITP patients balances pressure distribution, safety during potential bleeding events, and accommodation of treatment-related side effects.

Side sleeping: This is the most common sleep position and works well for most ITP patients if the mattress provides adequate pressure relief at the shoulder and hip. Side sleeping keeps the airway open and allows easy drainage if a nosebleed occurs during sleep, preventing choking on blood. Place a pillow between the knees to reduce hip and knee pressure. Alternate sides during the night to prevent prolonged pressure on one set of contact points.

Back sleeping: This position distributes weight most evenly and may be preferable during periods of very low platelet counts when minimizing pressure is the primary concern. However, back sleeping can worsen nasal congestion and increase the risk of choking if a nosebleed occurs. If you sleep on your back, elevate your head slightly (10 to 15 degrees) with an extra pillow to facilitate nasal drainage and reduce facial capillary pressure.

Elevated upper body: Patients on corticosteroids who experience acid reflux (a common side effect) may benefit from sleeping with the upper body elevated by 15 to 30 degrees. This position reduces the backflow of stomach acid into the oesophagus. An adjustable bed frame or a wedge pillow can achieve this elevation. Ensure the mattress supports the altered weight distribution without creating excessive pressure in the lower back and pelvis area.

Positions to avoid: Stomach sleeping is generally not recommended for ITP patients. This position creates concentrated pressure on the chest and pelvis, which are areas rich in small blood vessels. It also places strain on the neck and lower back. If you naturally gravitate toward stomach sleeping, try transitioning to a three-quarter prone position (somewhere between stomach and side) with a body pillow to provide the chest-down feeling without the full pressure of stomach sleeping.

Position changes: Natural position changes during the night are beneficial for ITP patients because they redistribute pressure. A responsive mattress that facilitates easy movement encourages these natural shifts. If you tend to stay in one position for long periods, setting a gentle vibrating alarm (placed under the pillow or mattress) at one or two points during the night can prompt a position change without fully waking you.

Bedroom Setup for ITP Safety

Beyond the mattress itself, the overall bedroom setup can contribute to both safety and sleep quality for ITP patients.

Mattress protector: A waterproof, breathable mattress protector is strongly recommended for ITP patients. Unexpected nosebleeds, gum bleeding, or heavy menstrual flow can stain and damage an unprotected mattress. The protector should be thin and smooth to avoid adding unwanted texture to the sleep surface. Many modern waterproof protectors use a thin polyurethane membrane that blocks moisture while allowing air to pass through, maintaining the mattress's breathability.

Bedside supplies: Keep tissues, a small towel, and a flashlight within easy reach of the bed. For patients prone to nosebleeds, having nasal packing material or a nosebleed clip on the nightstand allows quick treatment without the stress of searching for supplies in the dark. A dark-coloured towel can be placed over the pillow during periods of very low platelet counts to reduce anxiety about blood staining.

Bed height: The height of the bed (mattress plus foundation) affects how easy it is to get in and out safely. A bed that is too high requires a larger step up, increasing the risk of losing balance. A bed that is too low requires more effort to stand up from, which can be difficult for patients who experience dizziness. The ideal height allows you to sit on the edge with your feet flat on the floor and your knees at approximately a 90-degree angle.

Bedroom lighting: If you need to get up during the night (for bleeding management, bathroom visits, or medication), having a path illuminated by low-level nightlights reduces the risk of bumping into furniture, which could cause bruising. Motion-activated nightlights are particularly convenient as they provide light only when needed without requiring you to fumble for switches.

Bedding selection: Use smooth, tightly woven cotton or bamboo-derived sheets to minimize skin friction. Avoid flannel or textured bedding that can create shearing forces. Dark-coloured sheets and pillowcases can reduce the visual stress of any minor bleeding that occurs during sleep, as bloodstains are less visible on dark fabrics.

Canadian ITP Resources and Support

Canada has a growing network of ITP-specific and broader bleeding disorder resources that can support patients in improving their overall quality of life, including sleep.

The Platelet Disorder Support Association (PDSA) provides education, support, and advocacy for ITP patients in North America, including Canada. Their online resources include patient forums where individuals share practical tips for managing daily challenges, and their annual conference brings together patients, caregivers, and healthcare providers to discuss the latest in ITP care.

The Canadian Hematology Society (CHS) provides clinical practice guidelines for the management of ITP in Canada. These guidelines are increasingly recognizing the importance of quality-of-life measures, including fatigue and sleep, as treatment outcomes beyond platelet counts alone. Patients can discuss these guidelines with their haematologists to ensure their care addresses all aspects of the disease.

Provincial health coverage for ITP treatment varies across Canada. Ontario's OHIP covers haematology consultations and most ITP medications, though some newer therapies may require special authorization through the Exceptional Access Program. The Trillium Drug Program provides coverage for Ontarians whose drug costs are high relative to their income. Patients should work with their treatment centre social worker to maximize available coverage.

The Restonic ComfortCare for ITP Patients

The Restonic ComfortCare line, available at Mattress Miracle in Brantford, addresses the specific needs of ITP patients through its combination of high-count individually wrapped coils, responsive comfort layers, and breathable construction.

The Queen-size model features 1,222 individually wrapped coils that provide exceptionally even pressure distribution. For ITP patients whose capillaries are more vulnerable due to low platelet counts, this even distribution reduces the peak pressure at any single contact point, minimizing the mechanical stress that can contribute to bruising and petechiae. The King-size model, with 1,440 coils, provides even finer contouring for patients who prefer a larger sleep surface or who need extra room for pillow arrangements.

The responsive comfort layers allow easy position changes that help ITP patients naturally redistribute pressure throughout the night. Unlike dense memory foam that sinks slowly and resists repositioning, the Restonic ComfortCare's comfort system responds quickly to body movement, facilitating the natural shifts that prevent prolonged pressure on any single area.

The open coil support system promotes airflow that helps manage the temperature fluctuations common in ITP patients on corticosteroids. The breathable construction dissipates body heat more effectively than all-foam mattresses, reducing night sweats and the position changes that heat discomfort triggers.

Shop: Shop The Full Mattress Lineup